Clemizole HCl ( DrugBank: Clemizole )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 144 | Lennox-Gastaut syndrome | 1 |
144. Lennox-Gastaut syndrome
Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05066217 (ClinicalTrials.gov) | October 1, 2022 | 23/9/2021 | EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome | A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox-Gastaut Syndrome | Lennox Gastaut Syndrome | Drug: Clemizole HCl;Drug: Placebo to match EPX-100 | Epygenix | NULL | Not yet recruiting | 14 Years | N/A | All | 24 | Phase 2 | NULL |